tm logo
CELLDEX THERAPEUTICS
Live/Registered
REGISTERED AND RENEWED

on 19 Jul 2019

Last Applicant/ Owned by

53 Frontage Road, Suite 220

Hampton

NJ

08827

Serial Number

78501454 filed on 18th Oct 2004

Registration Number

3641176 registered on 16th Jun 2009

in the Principal Register

Correspondent Address

Vanessa A. Ignacio, Esq.

Vanessa A. Ignacio, Esq.

One Lowenstein Drive

Roseland NJ 07068

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CELLDEX THERAPEUTICS

Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease

Classification Information


Class [005]
Pharmaceutical Products


Vaccines, therapeutic vaccines and therapeutic pharmaceuticals derived from monoclonal antibodies for use in the treatment of cancer, autoimmune disorders, infectious diseases and graft-verus-host disease


First Use Date in General

12th Jan 2009

First Use Date in Commerce

13th Apr 2009

Mark Details


Serial Number

No 78501454

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 20212.52

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.12 -

Circles with bars, bands and lines

26.01.21 -

Circles that are totally or partially shaded

Legal History


Show more

Status DateAction Taken
19th Jul 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
19th Jul 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
19th Jul 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
19th Jul 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Jun 2019TEAS SECTION 8 & 9 RECEIVED
16th Jun 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Aug 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
06th Aug 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
23rd Apr 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23rd Apr 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED